Barclays Initiates Coverage On Charles River with Equal-Weight Rating, Announces Price Target of $230
Charles River Laboratories International, Inc. +2.42% Pre
Charles River Laboratories International, Inc. CRL | 186.52 186.52 | +2.42% 0.00% Pre |
Barclays analyst Luke Sergott initiates coverage on Charles River (NYSE:
CRL) with a Equal-Weight rating and announces Price Target of $230.